# Molecular Mechanisms Underlying Prostate Cancer Disparities

> **NCT02229565** · — · COMPLETED · sponsor: **Duke University** · enrollment: 226 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Biopsy or prostatectomy

## Key facts

- **NCT ID:** NCT02229565
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-10-14
- **Final completion:** 2019-10-14
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229565, "Molecular Mechanisms Underlying Prostate Cancer Disparities". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02229565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*